Role of surgery in the treatment of motor complications

Movement Disorders

Volumn 20, Issue SUPPL. 11, 2005, Pages

  Metman, Leo Verhagen ^a   O'Leary, Shaun T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

DBS; Dyskinesias; Motor complications; Parkinson's disease; Surgical intervention

Indexed keywords

ANTIPARKINSON AGENT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE DECARBOXYLASE; LEVODOPA; PARVOVIRUS VECTOR; PLACEBO;

ARTICLE; BRAIN DEPTH STIMULATION; CELL TRANSPLANTATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG SAFETY; DYSKINESIA; EVIDENCE BASED MEDICINE; FETUS CELL; GAMMA KNIFE RADIOSURGERY; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; MOTOR DYSFUNCTION; NEUROSURGERY; NONHUMAN; PALLIDOTOMY; PARKINSON DISEASE; PIGMENT EPITHELIUM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; SURGICAL TECHNIQUE; THALAMOTOMY; VALIDATION PROCESS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; DYSKINESIA, DRUG-INDUCED; GLOBUS PALLIDUS; HUMANS; LEVODOPA; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; THALAMUS;

EID: 20544476105     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20480     Document Type: Article

References (96)

1. Papa SM, Desimone R, Fiorani M, Oldfield EH. Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann Neurol 1999;46:732-738.
2. Boraud T, Bezard E, Bioulac B, Gross CE. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain 2001;124:546-557.
3. Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano AM. Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease. J Neurophysiol 2001;86:249-260.
4. Stefani A, Stanzione P, Bassi A, Mazzone P, Vangelista T, Bernardi G. Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and internal globus pallidus activity. J Neural Transm 1997;104:895-904.
5. Mitchell IJ, Clarke CE, Boyce S, et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 1989;32:213-226.
6. Brooks DJ, Piccini P, Turjanski N, Samuel M. Neuroimaging of dyskinesia. Ann Neurol 2000;47(Suppl. 1):S154-S159.
7. Rascol O, Sabatini U, Brefel C, et al. Cortical motor over activation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. Brain 1998;121:527-533.
8. Lozano AM. Surgery for Parkinson's disease, the five W's: why, who, what, where, and when. Adv Neurol 2003;91:303-307.
9. Lang AE. Surgery for levodopa-induced dyskinesias. Ann Neurol 2000;47(Suppl. 1):S193-S199; discussion S199-S202.
10. Goetz CG, Koller WC, Poewe W, Rascol O, Sampaio C. Surgical treatment for Parkinson's disease: deep brain surgery. In: Management of Parkinson's disease: a evidence-based review. Mov Disord 2002;17(Suppl. 4):S128-S147.
11. Stowe RL, Wheatley K, Clarke CE, et al. Surgery for Parkinson's disease: lack of reliable clinical trial evidence. J Neurol Neurosurg Psychiatry 2003;74:519-521.
12. Hassler R. The influence of stimulations and coagulations in the human thalamus on the tremor at rest and its physiopathologic mechanism. Second International Congress of Neuropathology, Excerpta Medica Foundation. Amsterdam: Excerpta Medica; 1955. p 637-642.
13. Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000;342:461-468.
14. Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 1995;37:680-686.
15. Speelman JD, Schuurman PR, de Bie RM, Bosch DA. Thalamic surgery and tremor. Mov Disord 1998;13(Suppl. 3):103-106.
16. Matsumoto K, Asano T, Baba T, Miyamoto T, Ohmoto T. Long-term follow-up results of bilateral thalamotomy for parkinsonism. Applied Neurophysiol 1976;39:257-260.
17. Kelly PJ, Gillingham FJ. The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study. J Neurosurg 1980;53:332-337.
18. Narabayashi H, Yokochi F, Nakajima Y. Levodopa-induced dyskinesia and thalamotomy. J Neurol Neurosurg Psychiatry 1984;47: 831-839.
19. Caparros-Lefebvre D, Blond S, Vermersch P, Pecheux N, Guieu JD, Petit H. Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993;56:268-273.
20. Caparros-Lefebvre D, Pollak P, Feltin MP, Blond S, Benabid AL. The effect of thalamic stimulation on levodopa induced dyskinesias - evaluation of a new target: the center parafascicular median. Rev Neurol 1999;155:543-550.
21. Page RD, Sambrook MA, Crossman AR. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience 1993;55:147-165.
22. Meyers R. The modification of alternating tremors, rigidity and festination by surgery of the basal ganglia. Res Neur Merit Dis Proc 1942;21:602-665.
23. Laitinen LV, Bergenbeim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
24. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
25. Dogali M, Fazzini E, Kolodny E, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.
26. Baron MS, Vitek JL, Bakay RA, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40:355-366.
27. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-1042.
28. Fazzini E, Dogali M, Sterio D, Eidelberg D, Beric A. Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy. Neurology 1997;48:1273-1277.
29. Kishore A, Turnbull IM, Snow BJ, et al. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations. Brain 1997;120:729-737.
30. Krauss JK, Desaloms JM, Lai EC, King DE, Jankovic J, Grossman RG. Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis. J Neurosurg 1997;87:358-367.
31. Kopyov O, Jacques D, Duma C, et al. Microelectrode-guided posteroventral medial radiofrequency pallidotomy for Parkinson's disease. J Neurosurg 1997;87:52-59.
32. Uitti RJ, Wharen RE Jr, Turk MF, et al. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 1997;49:1072-1077.
33. Giller CA, Dewey RB, Ginsburg MI, Mendelsohn DB, Berk AM. Stereotactic pallidotomy and thalamotomy using individual variations of anatomic landmarks for localization. Neurosurgery 1998; 42:56-62.
34. Samuel M, Caputo E, Brooks DJ, et al. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. Brain 1998;121:59-75.
35. Shannon KM, Penn RD, Kroin JS, et al. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology 1998;50:434-438.
36. Kondziolka D, Bonaroti E, Baser S, Brandt F, Kim YS, Lunsford LD. Outcomes after stereotactically guided pallidotomy for advanced Parkinson's disease. J Neurosurg 1999;90:197-202.
37. Samii A, Turnbull IM, Kishore A, et al. Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study. Brain 1999;122:417-425.
38. Fine J, Duff J, Chen R, et al. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med 2000; 342:1708-1714.
39. de Bie RM, Schuurman PR, Bosch DA, de Haan RJ, Schmand B, Speelman JD. Dutch Pallidotomy Study Group. Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patients. J Neurol Neurosurg Psychiatry 2001;71:375-382.
40. Parkin SG, Gregory RP, Scott R, et al. Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: a case series of 115 patients. Mov Disord 2002;17:682-692.
41. Valldeoriola F, Martinez-Rodriguez J, Tolosa E, et al. Four year follow-up study after unilateral pallidotomy in advanced Parkinson's disease. J Neurol 2002;249:1671-1677.
42. Vitek JL, Bakay RA, Freeman A, et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann Neurol 2003;53:558-569.
43. de Bie RM, de Haan RJ, Nijssen PC, et al. Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicenter trial. Lancet 1999;354:1665-1669.
44. Goetz CG, Stebbins GT, Shale HM, et al. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord 1994;9:390-394.
45. Merello M, Nouzeilles MI, Kuzis G, et al. Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison. Mov Disord 1999;14: 50-56.
46. Young RF, Vermeulen S, Posewitz A, Shumway-Cook A. Pallidotomy with the gamma knife: a positive experience. Stereotact Funct Neurosurg 1998;70(Suppl. 1):218-228.
47. Okun MS, Stover NP, Subramanian T, et al. Complications of gamma knife surgery for Parkinson disease. Arch Neurol 2001;58: 1995-2002.
48. de Bie RM, Schuurman PR, Esselink RA, Bosch DA, Speelman JD. Bilateral pallidotomy in Parkinson's disease: a retrospective study. Mov Disord 2002;17:533-539.
49. Intemann PM, Masterman D, Subramanian I, et al. Staged bilateral pallidotomy for treatment of Parkinson disease. J Neurosurg 2001; 94:437-444.
50. Merello M, Starkstein S, Nouzeilles MI, Kuzis G, Leiguarda R. Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation. J Neurol Neurosurg Psychiatry 2001;71:611-614.
51. Counihan TJ, Shinobu LA, Eskandar EN, Cosgrove GR, Penney JB Jr. Outcomes following staged bilateral pallidotomy in advanced Parkinson's disease. Neurology 2001;56:799-802.
52. Favre J, Burchiel KJ, Taha JM, Hammerstad J. Outcome of unilateral and bilateral pallidotomy for Parkinson's disease: patient assessment. Neurosurgery 2000;46:344-353.
53. Gross RE, Lombardi WJ, Lang AE, et al. Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease. Brain 1999;122:405-416.
54. Hariz MI, Hirabayashi H. Is there a relationship between size and site of the stereotactic lesion and symptomatic results of pallidotomy and thalamotomy? Stereot Funct Neurosurg 1997;69:28-45.
55. Krack P, Pollak P, Limousin P, et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 1998;43: 180-192.
56. Bejjani B, Damier P, Arnulf I, et al. Pallidal stimulation for Parkinson's disease. Two targets? Neurology 1997;49:1564-1569.
57. Peppe A, Pierantozzi M, Altibrandi MG, et al. Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation. Eur J Neurol 2001;8:579-586.
58. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994;35:1126-1129.
59. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998;121:451-457.
60. Tronnier VM, Fogel W, Kronenbuerger M, Steinvorth S. Pallidal stimulation: an alternative to pallidotomy. J Neurosurg 1997;87: 700-705.
61. Pahwa R, Wilkinson S, Smith D, Lyons K, Miyawaki E, Koller WC. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology 1997;49:249-253.
62. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg 1998;89:713-718.
63. Kumar R, Lang AE, Rodriguez-Oroz MC, et al. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology 2000;55:12(Suppl. 6):S34-S39.
64. Krause M, Fogel W, Heck A, et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 2001;70: 464-470.
65. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2001;56:548-551.
66. Loher TJ, Burgunder JM, Pohle T, Weber S, Sommerhalder R, Krauss JK. Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J Neurosurg 2002;96:844-853.
67. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 1999;45:1375-1382.
68. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pairs interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
69. Visser-Vandewalle V, van der Linden C, Temel Y, Nieman F, Celik H, Beuls E. Long-term motor effect of unilateral pallidal stimulation in 26 patients with advanced Parkinson disease. J Neurosurg 2003;99:701-707.
70. Krack P, Pollack P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From off-period dystonia to peak-dose chorea: the clinical spectrum of varying subthalamic nucleus activity. Brain 1999;122: 1133-1146.
71. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-855.
72. Limousin P, Krack P, Pollack P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-1111.
73. Moro E, Scerrati M, Romito LMA, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999;53:85-90.
74. Ostergaard K, Sunde N, Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 2002;17:693-700.
75. Shults CW. Treatments of Parkinson disease. Arch Neurol 2003; 60:1680-1684.
76. Katayama Y, Kasai M, Oshima H, et al. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. J Neurosurg 2001;95:213-221.
77. Pinter MM, Alesch F, Murg M, Seiwald M, Helscher RJ, Binder H. Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic Parkinson's disease: one year follow-up. J Neural Transm 1999;106:693-709.
78. Houeto JL, Damier P, Bejjani PB, et al. Subthalamic stimulation in Parkinson's disease: a multidisciplinary approach. Arch Neurol 2000;57:461-465.
79. Molinuevo JL, Valldeoriola F, Tolosa E, et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson's disease. Arch Neurol 2000;57:983-988.
80. Lopiano L, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety. Neurology 2001;56:552-554.
81. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934.
82. Kopyov OV, Jaques DS, Lieberman A, Duma CM, Rogers RL. Outcomes following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue. Exp Neurol 1997;146:536-545.
83. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344:710-719.
84. Bakay RAE. Is transplantation to treat Parkinson's disease dead? Neurosurgery 2001;49:576-580.
85. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54:403-414.
86. Mendez I, Dagher A, Hong M, et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson's disease: a pilot study. J Neurosurg 2002;96:589-596.
87. Bakay RAE, Kordower J, Starr P. Restorative surgical therapies for Parkinson's disease. Cent Nerv Syst Regen 1999;14:389-417.
88. Ma Y, Feigin A, Dhawan V, et al. Dyskinesia after fetal cell transplantation for Parkinsonism: a PET study. Ann Neurol 2002; 52:628-634.
89. Hagell P, Piccini P, Bjorkland A, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002; 5:627-628.
90. Watts RL, Raiser CD, Stover NP, et al. Stereotactic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm Suppl 2003;65:215-227.
91. Grondin R, Zhand Z, Yi A, et al. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 2002;125:2191-2201.
92. Gill SS, Patel NK, Horton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003;9:589-595.
93. Lang AE, Gill S, Brooks D, et al. Multicenter, double-blind, randomized, placebo-controlled, Phase I-II trial of bilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (GDNF) in levodopa-responsive Parkinson's disease (PD): Preliminary results. Ann Neurol 2004;56:17A.
94. Burton EA, Glorioso JC, Fink DJ. Gene therapy progress and prospects: Parkinson's disease. Gene Ther 2003;10:1721-1727.
95. Luo J, Kaplitt MG, Fitzsimons HL, et al. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 2002;298:425-429.
96. Esselink RAJ, de Bie RMA, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD. A randomized trial. Neurology 2004;62:201-207.